ArticleInternational journal of emergency medicine2026
Saudi expert consensus on the management of acute asthma and COPD exacerbations with algorithm of aerosol drug delivery device recommendations.
Article in International journal of emergency medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo develop a practical, expert consensus for the management of acute asthma and chronic obstructive pulmonary disease (COPD) exacerbations in Saudi Arabia's Emergency Departments (EDs), addressing gaps in triage, diagnostic certainty, and aerosol delivery.
methodsA modified expert consensus process with Delphi elements was employed. Eight multidisciplinary experts in pulmonary medicine, emergency medicine, and respiratory therapy, three of whom were affiliated with the Saudi Society of Emergency Medicine (SASEM), two of whom are authors of the Saudi initiative for Asthma (SINA) Guidelines, and three of whom are authors of the Saudi COPD guidelines, reviewed evidence-based presentations and formulated structured discussion questions before the meeting. The advisory board session (Riyadh, November 19, 2025) served as the formal consensus round, addressing ten predefined clinical questions across two moderated debate sessions, with formal voting on two key device-selection statements.
resultsThe panel adopted a dual-phase severity classification: a binary "Non-Severe vs. Severe" model for rapid ED triage, followed by the four-tier SINA classification for clinical management. Pharmacological algorithms were standardized, prioritizing early corticosteroid therapy and optimizing bronchodilator dosing to mitigate toxicity. The panel reached a unanimous consensus that aerosol delivery device selection significantly influences treatment success; A-VMN was recommended at escalating strengths across severity levels (Class IIb-I) and as a preferred option for severe and ventilated patients, based on superior lung deposition, infection control advantages, and improved discharge rates.
conclusionThis modified expert consensus aims to provide an up-to-date, organized, and action-oriented protocol for Saudi EDs. It advocates a stratified triage system and evidence-based selection of aerosol-delivery devices to improve patient outcomes, enhance safety, and optimize resource utilization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.